Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.54 |
| ▸ | MAOB | P27338 | 1/20 | 0.54 |
| ▸ | ATM | Q13315 | 2/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.42 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.42 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.42 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.42 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19458502 | 0.90 | MAOA (0.64) | MAOAMAOBATMHDAC3HDAC4 | |
| SCHEMBL4382002 | 0.83 | MAOA (0.47) | MAOAMAOBATMHDAC3HDAC4 | |
| SCHEMBL524603 | 0.82 | GPR3 (0.50) | ATMHDAC3HDAC4HDAC7HDAC8 | |
| SCHEMBL29950614 | 0.82 | GPR3 (0.50) | ATMHDAC3HDAC4HDAC7HDAC8 | |
| SCHEMBL23818652 | 0.77 | MAPK1 (0.37) | MAOAMAOBATMCYP2C9MEN1 | |
| SCHEMBL7535279 | 0.74 | MAOA (0.52) | MAOAMAOBATMHDAC3HDAC4 | |
| SCHEMBL28627118 | 0.73 | MAOA (0.45) | MAOAMAOBATMHDAC3HDAC4 | |
| SCHEMBL8516771 | 0.73 | MAOA (0.50) | MAOAMAOBATMHDAC3HDAC4 | |
| SCHEMBL29056534 | 0.72 | MAOA (0.61) | MAOAMAOBATMHDAC3HDAC4 | |
| SCHEMBL16835547 | 0.72 | MAOA (0.61) | MAOAMAOBATMHDAC3HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102786508-A | Spiro-fluorene-9,9-xanthene bipolar luminescent material, its preparation method and its application method | UNIV NANJING POSTS & TELECOMM | 2012-11-21 | — | — | CN | claimed |
| EP-0891344-A1 | ALPHA 1-ADRENERGIC RECEPTOR ANTAGONISTS | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 1999-01-20 | — | — | EP | claimed |
| WO-1997037983-A1 | α1-ADRENERGIC RECEPTOR ANTAGONISTS | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 1997-10-16 | — | — | WO | claimed |
| US-20210286266-A1 | MATERIAL FOR FORMING ORGANIC FILM, METHOD FOR FORMING ORGANIC FILM, PATTERNING PROCESS, AND COMPOUND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-09-16 | — | — | US | disclosed |
| CN-102786508-A | Spiro-fluorene-9,9-xanthene bipolar luminescent material, its preparation method and its application method | UNIV NANJING POSTS & TELECOMM | 2012-11-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210286266-A1 | MATERIAL FOR FORMING ORGANIC FILM, METHOD FOR FORMING ORGANIC FILM, PATTERNING PROCESS, AND COMPOUND | EPCAM, CDH1, DNMT3L | MAOA 275/4885MAOB 424/4885ATM 1629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.